Drug-Interaction Study to Evaluate the Effect of Rifampin, a Potent CYP3A4 Inducer, on the Systemic Exposure of Pacritinib in Healthy Subjects
Part of paid clinical trials in Daytona Beach, Florida.
- Sponsor
- CTI BioPharma
- Study ID
- NCT02807116
- Phase
- PHASE1
- Status
- Completed
Conditions
- Healthy Subjects
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 55 Years
- Healthy Volunteers
- Accepted
Interventions
- Pacritinib — DRUGSubjects received a single oral 400-mg dose of pacritinib
- Rifampin — DRUGSubjects received 600-mg oral doses of rifampin; administered QD following a 7-day washout period
- Pacritinib and Rifampin — DRUGOn Day 17, a single oral 400-mg dose of pacritinib was co-administered with the final 600-mg dose of rifampin.
Study Details
The primary objective is to evaluate the effect of rifampin, a potent cytochrome P450 3A4 inducer, at steady-state on the systemic exposure of a single dose of pacritinib in healthy subjects.
Key Dates
- Start date
- Jan 31, 2015
- Status verified
- Jun 2016
- Primary completion
- Feb 28, 2015
- Completion
- Feb 28, 2015
Study Design
- Enrollment
- 18 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- OTHER
Arms
- Experimental: Pacritinib and RifampinOn Day 1, subjects received a single oral 400-mg dose of pacritinib. On Days 8 through 17, following a 7-day washout period, 600-mg oral doses of rifampin were administered QD. It was anticipated that steady-state concentrations of rifampin would be achieved by Day 17. On Day 17, a single oral 400-mg dose of pacritinib was co-administered with the final 600-mg dose of rifampin.
Primary Outcome Measure
Estimate ratios of geometric mean values and the corresponding 90% confidence intervals (CIs) for pacritinib treatments with and without rifampin [ Time Frame: Approx. one month ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Covance Clinical Research Unit | Daytona Beach | Florida | 32117 | - |
Find similar trials in Daytona Beach, FL
By research site
Related Studies
- High Frequency Stimulation to Improve Cognition, Mobility, and Affect in Individuals With and Without Subjective Cognitive DeclineNot Yet Recruiting · University of Florida · Gainesville, Florida
- Oral Bacteria and Immune System Problems Involved in Gum Disease (Periodontitis)Recruiting · National Institute of Dental and Craniofacial Research (NIDCR) · Bethesda, Maryland
- Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR)Recruiting · National Heart, Lung, and Blood Institute (NHLBI) · Bethesda, Maryland
- Optimizing Ultrasound-induced Anti-inflammation in Human SubjectsRecruiting · University of Virginia · Charlottesville, Virginia